Seven Mile Advisory’s Sanofi SNY Stock Holding History

Seven Mile Advisory’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-3,845	Closed	-$206K	–	155
2023 Q3	$206K	Buy	+3,845	New	+$205K	0.22%	111

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Seven Mile Advisory's SNY Position: Q4 2023 in Review

Seven Mile Advisory sold out of Sanofi (SNY) in Q4 2023, closing a stake of 3,845 shares — an estimated $206K sold.

Seven Mile Advisory first reported a position in SNY in Q3 2023 and held it in 1 quarter. The position peaked at $206K in Q3 2023. 708 funds tracked by Wall St. Rank hold SNY as of Q4 2023.

Seven Mile Advisory reported no remaining Sanofi position as of Q4 2023 after selling out during the quarter.
Seven Mile Advisory sold 3,845 Sanofi shares in Q4 2023, an estimated $206K.
Seven Mile Advisory first reported a position in Sanofi in Q3 2023 and held it in 1 quarter.
Seven Mile Advisory's Sanofi position peaked at $206K in Q3 2023.
708 funds tracked by Wall St. Rank held Sanofi as of Q4 2023.

Based on Seven Mile Advisory's 13F filing for Q4 2023, filed 9 Feb 2024.